Gene Therapy Net Newsletter |
|

|
News: EU approves Hemgenix, one-time gene therapy for hemophilia B
|
|
The European Commission has conditionally approved Hemgenix (etranacogene dezaparvovec), a one-time gene therapy to treat adults with hemophilia B. Hemgenix, originally developed by uniQure, is approved for adults with severe and moderately severe hemophilia B without a history of inhibitors. It’s the first gene therapy for hemophilia B available to patients across all European Union member states, plus Iceland, Liechtenstein, and Norway.
Read more…
|
|
|
Conference: Next Generation Cardiovascular Drug Development Summit
|
|
The Next Generation Cardiovascular Drug Development Summit (April 25 - 27) is biopharma’s unmissable meeting for the expedition of treatment for cardiovascular disease patients. With 3 days of abundant insights into the latest breakthroughs and research and a faculty of world-class speakers pioneering the next wave of novel and precise cardiovascular therapeutics, ensure you don’t miss out on this valuable forum.
This inaugural summit will delve deep into the understanding of genetic components of cardiovascular disease, utilisation of imaging biomarkers, delivery of precise cardiac therapeutics, optimization of preclinical animal models, and overcoming off-target genome editing to mitigate against toxicity and long-term effects and unlock the potential of novel biologics.
Register now…
|
|
|
Conference: 6th Annual Pharmaceutical Microbiology USA Conference
|
|
We are delighted to announce 6th Annual Pharmaceutical Microbiology USA conference taking place in Boston on the April 26-27. Microbiology remains an essential tool for the detection of microorganisms to protect patients globally.
This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods, data integrity and the recent updates in Annex 1.
Register now…
|
|
|
Conference: Influenza mRNA Vaccines - lipid nanoparticle delivery
|
|
The brand-new digital conference, Influenza mRNA Vaccines, is taking place on April 27. Created by the TIDES San Diego team, this is an exciting new event to upgrade your knowledge on next-generation mRNA approaches. Register to step into the future of influenza vaccines and discover how technologies developed and popularised during the COVID response can be utilized to create safe and regulatory approved vaccines for the influenza virus. This is your opportunity to hear from an unmissable line up of speakers who are changing the vaccination landscape from the likes of Moderna, University of Pennsylvania, Pfizer, Sanofi and The World Health Organisation. Save 10% on your pass with our exclusive discount code GTN10! Register now…
|
|
|
Conference: 4th Gene Therapy Analytical Development Europe Summit
|
|
Uniting leading CMC, Regulatory, QC, Analytical and Process Development experts, the 4th Annual Gene Analytical Development Europe Summit (May 2-4) is the industry’s definitive and only meeting focused on tackling the greatest analytical development challenges in the context of gene therapy drug development. Hear from the likes of AstraZeneca, MHRA, Gyroscope, REGENXBIO, Biogen, Spark Therapeutics, and more across three days and two tracks of in-depth case studies, interactive panel discussions, dedicated Q&A time, and highly appraised networking opportunities to meet and learn from the leaders of this pioneering field. Don’t miss the opportunity to network with 80+ analytical experts to overcome your analytical challenges encountered in every stage of the gene therapy development life cycle.
Register now…
|
|
|
Conference: ISBioTech Nucleic Acids 2023
|
|
Join the International Society for Bioprocess Technology May 8–10 in Savannah, Georgia USA for their 2023 Nucleic Acids event! Designed for professionals working at the forefront of nucleic acid technology worldwide, this conference covers the development, manufacturing, and analysis of DNA & RNA therapeutics utilizing both cell-based and cell-free processes. This includes the raw materials necessary for in vitro replication and/or transcription with a focus on the acquisition of high-quality nucleotides and recombinant enzymes. The meeting will also consider drug product formulations and nanoparticle delivery systems, including the associated raw materials, with lipids as a particular focus.
ISBioTech meetings offer an unparalleled opportunity to meet and network with top scientists, engineers, and supply firms in the biotech industry. You’ll learn and share with the industry’s leading organizations as you hear from the individuals actually doing the work in labs and production suites.
Live virtual access to talks, plus access to some recorded presentations following the conclusion of the meeting is included. Register by March 13th at the reduced rate. Register now…
|
|
|
Conference: Global Bioprocessing Summit & Exhibition
|
|
The Global Bioprocessing Summit (May 10-12) brings together industry leaders to share day-to-day challenges and practical solutions for the development of biotechnology industry. 2 overarching topics are: 1. DOWNSTREAM PROCESSING & CONTINUOUS BIOMANUFACTURING Industry experts will discuss how to optimize technologies and process setups, manufacturing challenges, and strategies. And 2. ATMP TECHNOLOGIES FOR CELL & GENE THERAPIES The track includes considerations around manufacturing ATMPs, from closed loop systems for cell therapy to decentralized sites. Our participants get to enjoy an exclusive VIP tour with the latest laboratory at TU-Berlin! Register now…
|
|
|
Conference: 2nd Next Generation RNA Therapeutics Summit
|
|
The 2nd Next Generation RNA Therapeutics Summit (May 16-18) returns as the only industry-dedicated forum solely focused on next generation RNA therapeutics and vaccines that are more targeted and efficacious to accelerate their therapeutic and commercial potential. Expect exclusive data from senior industry-experts on the most recent developments in circRNAs, saRNAs, eRNAs & tRNAs therapies. Join 100+ thought leaders from the likes of Pfizer, Orna Therapeutics, Laronde, Replicate Bioscience and BioNTech to stay ahead of the curve and maximize the full therapeutic potential of next generation RNA modalities to gain clinical proof concept and reach patients in need. Catch all event information in the 2023 agenda. Register now…
|
|
|
Upcoming conferences and meetings
|
|
- 20 - 22 March 2023 - 12th Spring Meeting of the International Society for BioProcess Technology - Norfolk, VA
- 20 - 23 March 2023 - 6th Annual Gene Therapy for Rare Disorders 2023 Summit - Boston, MA
- 28 - 29 March 2023 - Reuters Pharma USA 2023 - Cell and Gene Therapies - Philadelphia, PA
- 28 - 29 March 2023 - International Bioprocessing and Biologics 2023 - Cell and Gene Therapies - Berlin, Germany
- 28 - 30 March 2023 - 8th Innate Killer Summit - San Diego, CA
- 28 - 30 March 2023 - 3rd Gene Therapy Comparability Summit - Boston, MA
- 17 - 19 April 2023 - 2nd LNP Formulation & Process Development Summit 2023 - Gene Therapy delivery - Boston
- 18 - 20 April 2023 - mRNA Process Development & Manufacturing Summit Europe - Frankfurt, Germany
- 24 - 25 April 2023 - The Economist's Cell & Gene Therapy summit - Brussels, Belgium
- 25 - 27 April 2023 - Gene Therapy Durability Summit - Boston, MA
- 25 - 27 April 2023 - Next Generation Cardiovascular Drug Development Summit - Boston, MA
- 26 - 27 April 2023 - World Oncology Cell Therapy Congress USA - Boston, MA
- 26 - 27 April 2023 - 6th Annual Pharmaceutical Microbiology USA Conference - Cell therapies - Boston, MA
- 27 April 2023 - Influenza mRNA Vaccines - lipid nanoparticle delivery - Online event
- 2 - 4 May 2023 - 4th Gene Therapy Analytical Development Europe Summit - London, UK
- 2 - 4 May 2023 - 2nd iPSC Manufacturing Summit - Gene Engineering - Boston, MA
- 8 - 10 May 2023 - ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics - Savannah, GA
- 10 - 12 May 2023 - Bioprocessing Events 2023 - Berlin, Germany
- 16 - 18 May 2023 - 2nd Next Generation RNA Therapeutics Summit - Boston, MA
- 17 - 20 May 2023 - American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting - Los Angeles, CA
- 22 - 25 May 2023 - 5th Annual Allogeneic Cell Therapies Summit - Boston, MA
- 23 - 24 May 2023 - Global Biologics Cell and Gene Legal Summit - Brussels, Belgium
- 23 - 25 May 2023 - World Orphan Drug Congress USA 2023 - Washington, D.C.
- 26 - 28 May 2023 - Symposium on World Cell and Molecular Biology 2023 - Singapore
- 30 May - 1 June 2023 - 5th Treg Summit - Boston, MA
- 6 - 8 June 2023 - Gene Therapy for Neurological Disorders Summit Europe - Amsterdam, The Netherlands
- 12 - 13 June 2023 - Annual meeting of the Netherlands Society of Gene & Cell Therapy - Lunteren, The Netherlands
- 13 - 15 June 2023 - 3rd Gene Therapy Patient Engagement Summit - Boston, MA
- 26 - 29 June 2023 - Gene Therapy & Rare Diseases conference - Boston, MA
- 27 - 29 June 2023 - Next Generation Gene Therapy Vectors Summit - Boston, MA
- 11 - 13 July 2023 - 4th RNA Editing Summit - Boston, MA
- 26 - 28 July 2023 - 3rd Annual mRNA-Based Therapeutics Summit - Boston, MA
- 9 August 2023 - Drug Discovery and Development - Cell & Gene Therapies - London, UK
- 27 - 29 September 2023 - Smart Bioprocessing & Pharma 4.0 Summit - Cell & Gene Therapies - Berlin, Germany
- 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium
|
|
|
|